[ad_1]
Johnson & Johnson halted clinical trials of a candidate for the COVID-19 vaccine after a vaccine volunteer experienced an “unexplained illness.” The health status of the volunteers is being monitored and evaluated by the Data Security Monitoring Board (DSMB).
As for the condition of the volunteers, JNJ did not provide a more detailed explanation because it was related to the privacy in question. It is also not known whether the volunteers received the vaccine or the placebo.
Meanwhile, another candidate vaccine made by Sinovac in collaboration with Bio Farma is also undergoing clinical trials in Bandung, West Java. Is there any chance you will be arrested for the same thing?
“We see from experience. At that time Astrazeneca held it, but it was revised. After seeing it, it was continued again, so it did not stop immediately,” explained Professor Herawati Sudoyo, a molecular biology scientist who is also deputy director of the Institute. Eijkman, during the LaporCOVID discussion. -19, Tuesday (10/13/2020).
According to Professor Hera, clinical trials of vaccines will stop if they have a harmful effect. An impact evaluation will be conducted and managed by the agency that created it.
Meanwhile, the Chairman of the Covid-19 Vaccine Research Testing Team of the University of Padjadjaran, Professor Dr. Kusnandi Rusmil, SpA (K), MM, also added that in vaccine testing there are three main targets that should be achieved. Professor Kusnandi is currently leading the Sinovac vaccine clinical trial in Bandung.
“The first is the safety of the vaccines, the second is immunogenicity, and the third is efficacy. That’s the main thing,” he said.
Watch video “Corona Sinovac Vaccine Test – Produces 90% More Antibodies “
[Gambas:Video 20detik](start)
